Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Edition
European
US
Dermatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Early Skin Manifestations in a Newly Defined Autoimmune Disease
1
Mins
July 2024
Recent study highlights the early skin manifestations of VEXAS syndrome
Read more
1
Mins
4th October 2021
Are Gut Microorganisms the Key to Healthier Skin?
IMBALANCE in the gut’s microbiome, caused by a diet high in sugar and fats, may contribute to inflammatory skin diseases such as psoriasis…
1
Mins
4th October 2021
Could Enzyme Treatments Unlock the Secrets of the Skin Microbiome?
NEW research methodologies, which take advantage of enzymes in order to breakdown bacteria living on human skin, have revealed novel…
1
Mins
2nd July 2021
Ruxolitinib Cream Effective for Patients with Atopic Dermatitis
A study by Kim Papp looked at ruxolitinib as a topical cream for AD. Ruxolitinib works by inhibiting JAK1 and JAK2 on the cell surface and consequently affects the signalling cascade that would eventually produce pro-inflammatory cytokines.
1
Mins
2nd July 2021
Painful Psoriasis Flares Reduced by Switching to Balanced Diet
PSORIASIS is a painful inflammatory skin disease that affects approximately 125 million individuals worldwide. Currently, there is no cure for psoriasis.
1
Mins
31st March 2021
Development of a Microneedle Array for Noninvasive Drug Delivery
HOME healthcare systems are critical for improving medical care during infectious disease epidemics and for overcoming the growing challenges of an…
1
Mins
31st March 2021
Could Skin Swabbing be the Next COVID-19 Diagnostic Test?
MASS testing for coronavirus disease (COVID-19) has been identified by the World Health Organization (WHO) and many governments as a key strategy to…
1
Mins
8th January 2021
Can the Skin Predict Development of Heart Disease?
PERSONALISED precision medicine is expanding into predictive capabilities, as researchers from Thomas Jefferson University, Philadelphia, Pennsylvania…
1
Mins
8th January 2021
Atopic Dermatitis and Risk of Autoimmune Disease
COMORBID autoimmune disease has been linked to diagnosis with atopic dermatitis in patients over 15 years. Case control study data from Sweden…
Loading posts...
« Previous
1
…
4
5
6
7
8
…
16
Next »